机构：[1]Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College,Kunming, People's Republic of China,[2]Yunnan Key Laboratory of Vaccine Research & Development onSevere Infectious Diseases, Kunming, People's Republic of China,[3]Yunnan Key Laboratory of Vector-borneInfectious Disease, Kunming, People's Republic of China,[4]The First Affiliated Hospital of Kunming MedicalUniversity, Kunming, People's Republic of China,昆明医科大学附属第一医院[5]The Third Affiliated Hospital of Kunming MedicalUniversity, Yunnan Provincial Tumor Hospital, Kunming, People's Republic of China,外科科室肿瘤科昆明医科大学附属第一医院[6]Kunming MedicalUniversity, Kunming, People's Republic of China
HPV-16 long control region (LCR) has been shown to be the most variable region of the HPV-16 genome and may play important roles in viral persistence and the development of cervical cancer. This study aimed to assess the risk of HPV-16 LCR variants for cervical cancer in women of Southwest China. 2146 cervical scrapings of volunteer outpatients and 74 cervical cancer tissues were screened. 14 entire HPV-16 LCRs from asymptomatic carriers and 34 entire HPV-16 LCRs from cervical cancer patients were successfully amplified and sequenced to align to others described. 58 different point mutations were detected in 54 nucleotide sites of HPV-16 LCR. G7193T and G7521A variants, accounting for 100% of the infections, were predicted to locate at the binding site for FOXA1 and SOX9, respectively. A7730C variant which showed a high mutation frequency in cervical cancer was predicted to be a binding site for the cellular transcription factor PHOX2A. In addition, phylogenetic analysis displayed a high prevalence of A lineage in HPV-16 LCR in this Southwest China population. This study may help understanding of the intrinsic geographical relatedness and the correlations between LCR mutations and the development of carcinogenic lesions in Southwest China population. And it provides useful data for the further study of the biological function of HPV-16 LCR variants.
基金：
CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-026]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81171946]; National "Twelfth Five Year" "major new drug discovery" technology major projects [2012ZX09104-302]; Natural Science Foundation of Yunnan ProvinceNatural Science Foundation of Yunnan Province [2009ZC187M, 2012F6188, 2016FA029]
第一作者机构：[1]Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College,Kunming, People's Republic of China,[2]Yunnan Key Laboratory of Vaccine Research & Development onSevere Infectious Diseases, Kunming, People's Republic of China,[3]Yunnan Key Laboratory of Vector-borneInfectious Disease, Kunming, People's Republic of China,
通讯作者：
通讯机构：[1]Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College,Kunming, People's Republic of China,[2]Yunnan Key Laboratory of Vaccine Research & Development onSevere Infectious Diseases, Kunming, People's Republic of China,[3]Yunnan Key Laboratory of Vector-borneInfectious Disease, Kunming, People's Republic of China,
推荐引用方式(GB/T 7714)：
Juemin Xi,Junying Chen,Miaoling Xu,et al.Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China[J].PLOS ONE.2017,12(8):doi:10.1371/journal.pone.0182388.
APA：
Juemin Xi,Junying Chen,Miaoling Xu,Hongying Yang,Jia Luo...&Qiangming Sun.(2017).Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.PLOS ONE,12,(8)
MLA：
Juemin Xi,et al."Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China".PLOS ONE 12..8(2017)
